Journal
INVESTIGATIONAL NEW DRUGS
Volume 35, Issue 4, Pages 509-517Publisher
SPRINGER
DOI: 10.1007/s10637-017-0449-9
Keywords
Lung cancer; beta-glucans; Immunomodulatory activity; Drug resistance
Categories
Ask authors/readers for more resources
The potential of natural substances with immunotherapeutic properties has long been studied. beta-glucans, a cell wall component of certain bacteria and fungi, potentiate the immune system against microbes and toxic substances. Moreover, beta-glucans are known to exhibit direct anticancer effects and can suppress cancer proliferation through immunomodulatory pathways. Mortality of lung cancer has been alarmingly increasingly worldwide; therefore, treatment of lung cancer is an urgent necessity. Numerous researchers are now dedicated to using beta-glucans as a therapy for lung cancer. In the present attempt, we have reviewed the studies addressing therapeutic effects of beta-glucans in primary and metastatic lung cancer published in the time period of 1991-2016.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available